Buy RXRX near 6.2 target 8.05 stop loss @ 6.18 Details The technical summary data tells us to buy RXRX near 6.2 with an upside target of 8.05. This data also tells us to set a stop loss @ 6.18 to ...

Centaurus Financial Inc. bought a new stake in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the ...

Morgan Stanley has recently initiated Recursion Pharmaceuticals Inc (RXRX) stock rating, as announced on May 22, 2023, according to Finviz. Earlier, on March 16, 2023, Needham had initiated the stock ...

On Tuesday, Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $5.89 which represents a decrease of $-0.11 or -1.83% from the prior close of $6. The stock opened at $5.97 and ...

Moderna’s top executives have sought to reassure investors they will be able to carry out the comeback plans announced in ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

EST Cathie Wood’s ARK Investment buys 383K shares of Recursion Pharmaceuticals (RXRX) todayDon't Miss our Black Friday Offers:Discover ...

The latest announcement is out from Recursion Pharmaceuticals ( (RXRX) ).

Absci Corporation has secured key partnerships but lacks advanced assets. Find out why ABSI stock is still a speculative ...

Recursion struggles with losses and high cash burn despite a $500M IPO. See why RXRX stock remains a "Hold" amid funding ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report)’s stock price was down 4.9% on Friday following insider selling activity. The company traded as low as $6.52 and last traded at $6.57.

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading more than 100% higher on Wednesday after the techbio company announced a $50 million investment by Nvidia ...